サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1301153

灌流システムの市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2023年～2030年

Perfusion Systems Market Size, Share & Trends Analysis Report By Application (Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-vivo Organ Perfusion System), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
灌流システムの市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年06月29日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

灌流システム市場の成長と動向

世界の灌流システム市場規模は2030年までに15億米ドルに達すると予測されています。

さらに、同市場は2023年から2030年にかけてCAGR 4.7％で進展すると予測されています。慢性疾患の蔓延、臓器移植や多臓器不全の増加などの要因が市場成長を押し上げると予測されています。さらに、細胞ベースの研究への投資の増加や生物製剤製造の増加が、灌流システム産業の成長をさらに後押しすると予想されます。

パンデミックの前半には、灌流システムの売上が急減しました。世界の政府による封鎖や規制の結果、病院を訪れる患者の減少、手術件数の減少、研究開発活動の鈍化が生じた。しかし、ウイルスの蔓延を抑制し、将来の同様の事象に備えるための政府や医療関係者の取り組みが活発化したことで、市場は2021年に回復に転じ、予測期間中に隆盛を極めることが予想されます。

灌流システム市場レポートハイライト

  • 灌流システム市場は、用途別に心肺灌流システム、細胞灌流システム、生体外臓器灌流システムに区分されます。心疾患の世界の有病率の高さから、心肺灌流システムが2022年の市場を独占した
  • 地域別では、北米が2022年に最も高い市場シェアを占めました。慢性疾患の増加、確立されたヘルスケア部門、臓器提供者数の増加がこの地域の市場成長を牽引しています。
  • COVID-19パンデミックは灌流システム市場に大きな悪影響を与えました。ヘルスケアの優先順位の変化、社会的距離、世界の閉鎖などの要因により、手術件数が減少し、臓器提供や移植の件数が減少しました。
  • コロナウイルスの大流行により、灌流システムの売上は減少したが、パンデミックの第一波が去った後、市場は回復し、予測期間中にCOVID以前の成長レベルに達すると予想されます。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 調査手法
  • 情報調達
  • 情報またはデータ分析
  • 市場の形成と検証
  • モデル詳細
  • 二次情報のリスト
  • 一次情報のリスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
  • 競合考察

第3章 灌流システム市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/アンシラリー市場見通し
  • 普及と成長の見通しマッピング
  • 業界のバリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 灌流システム市場分析ツール
    • 業界分析- ポーターの分析
    • PESTEL分析
    • 主要取引と戦略的提携の分析
    • 市場参入戦略

第4章 灌流システム：用途の推定・動向分析

  • 定義と範囲
    • 心肺灌流システム
    • 細胞灌流システム
    • Ex-Vivo臓器灌流システム
  • 製品市場シェア、2021年と2030年
  • セグメントダッシュボード
  • 用途別の世界の灌流システム市場の見通し
  • 以下の市場規模、予測および動向分析、2018年から2030年まで
    • 心肺灌流システム
    • 細胞灌流システム
    • 体外灌流システム

第5章 灌流システム市場：地域推定・動向分析

  • 地域市場シェア分析、2022年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 地域市場シェアと主要企業、2022年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • SWOT分析、要因別（政治・法律、経済・技術）
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • 市場規模、予測、数量および動向分析、2018年から2030年：
  • 北米
    • 市場推計・予測、2018～2030年（収益）
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • シンガポール
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • イノベーター
  • ベンダー情勢
    • 主なディストリビューターとチャネルパートナーのリスト
    • 主な顧客
    • 主要企業の市場シェア分析、2022
    • Getinge AB
    • Medtronic, plc.
    • LivaNova,.
    • Terumo Corporation
    • Nipro Corporation
    • XENIOS AG
    • Repligen Corporation
    • Spectrum Laboratories, Inc.
    • Merck KGaA.
    • Harvard Bioscience, Inc.
    • ALA Scientific Instruments, Inc.
    • Lifeline Scientific, Inc.
    • XVIVO Perfusion AB
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 5 Canada perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 6 Europe perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 7 Europe perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.K. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 10 France perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 11 Italy perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 12 Spain. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 13 APAC. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 14 APAC perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 15 China perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 16 Japan perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 17 India perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 18 Latin America. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 19 Latin America perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 20 Brazil. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 21 Mexico perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 22 Argentina. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 23 Middle East and Africa. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 24 Middle East and Africa perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 25 South Africa. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 26 Saudi Arabia perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 27 UAE. perfusion system market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value - chain - based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Perfusion System: market outlook
  • Fig. 14 Perfusion System competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Perfusion System market driver impact
  • Fig. 20 Perfusion System market restraint impact
  • Fig. 21 Perfusion System market strategic initiatives analysis
  • Fig. 22 Perfusion System market: application movement analysis
  • Fig. 23 Perfusion System market: application outlook and key takeaways
  • Fig. 24 Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 25 Cardiopulmonary Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 26 Oxygenators market estimates and forecast, 2018 - 2030
  • Fig. 27 Heart - Lung Machine market estimates and forecast, 2018 - 2030
  • Fig. 28 Perfusion Pumps market estimates and forecast, 2018 - 2030
  • Fig. 29 Cannula market estimates and forecast, 2018 - 2030
  • Fig. 30 Monitoring Systems market estimates and forecast, 2018 - 2030
  • Fig. 31 Others market estimates and forecast, 2018 - 2030
  • Fig. 32 Cell Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 33 Bioreactor Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 34 Microfluidic Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 35 Gravity/Pressure - driven Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 36 Small Mammal Organ Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 37 Ex - Vivo Organ Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 38 Hypothermic market estimates and forecast, 2018 - 2030
  • Fig. 39 Normothermic market estimates and forecast, 2018 - 2030
  • Fig. 40 Global Perfusion System market: regional movement analysis
  • Fig. 41 Global Perfusion System market: regional outlook and key takeaways
  • Fig. 42 Global market share and leading players
  • Fig. 43 North America market share and leading players
  • Fig. 44 Europe market share and leading players
  • Fig. 45 Asia Pacific market share and leading players
  • Fig. 46 Latin America market share and leading players
  • Fig. 47 Middle East & Africa market share and leading players
  • Fig. 48 North America: SWOT
  • Fig. 49 Europe SWOT
  • Fig. 50 Asia Pacific SWOT
  • Fig. 51 Latin America SWOT
  • Fig. 52 MEA SWOT
  • Fig. 53 North America, by country
  • Fig. 54 North America
  • Fig. 55 North America market estimates and forecast, 2018 - 2030
  • Fig. 56 U.S.
  • Fig. 57 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 58 Canada
  • Fig. 59 Canada market estimates and forecast, 2018 - 2030
  • Fig. 60 Europe
  • Fig. 61 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 62 U.K.
  • Fig. 63 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 64 Germany
  • Fig. 65 Germany market estimates and forecast, 2018 - 2030
  • Fig. 66 France
  • Fig. 67 France market estimates and forecast, 2018 - 2030
  • Fig. 68 Italy
  • Fig. 69 Italy market estimates and forecast, 2018 - 2030
  • Fig. 70 Spain
  • Fig. 71 Spain market estimates and forecast, 2018 - 2030
  • Fig. 72 Russia
  • Fig. 73 Russia market estimates and forecast, 2018 - 2030
  • Fig. 74 Asia Pacific
  • Fig. 75 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 76 China
  • Fig. 77 China market estimates and forecast, 2018 - 2030
  • Fig. 78 Japan
  • Fig. 79 Japan market estimates and forecast, 2018 - 2030
  • Fig. 80 India
  • Fig. 81 India market estimates and forecast, 2018 - 2030
  • Fig. 82 Thailand
  • Fig. 83 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 84 Australia
  • Fig. 85 Australia market estimates and forecast, 2018 - 2030
  • Fig. 86 Australia
  • Fig. 87 Singapore market estimates and forecast, 2018 - 2030
  • Fig. 88 Latin America
  • Fig. 89 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 90 Brazil
  • Fig. 91 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 92 Mexico
  • Fig. 93 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 94 Argentina
  • Fig. 95 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 96 Middle East and Africa
  • Fig. 97 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 98 Saudi Arabia
  • Fig. 99 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 100 South Africa
  • Fig. 101 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 102 UAE
  • Fig. 103 UAE market estimates and forecast, 2018 - 2030
  • Fig. 104 Participant categorization - Perfusion System market
  • Fig. 105 Market share of key market players - Perfusion System market
目次
Product Code: GVR-1-68038-470-3

Perfusion Systems Market Growth & Trends

The global perfusion systems market size is projected to reach USD 1.5 billion by 2030, according to a new report by Grand View Research, Inc. Furthermore, the market is projected to advance at a CAGR of 4.7% from 2023 to 2030. Factors such as the growing prevalence of chronic diseases and the rise in the number of organ transplants and multiple organ failures are anticipated to boost the market growth. In addition, increasing investments in cell-based research and a rise in biologics manufacturing are further expected to impel the growth of the perfusion system industry.

There was a steep downfall in the sales of perfusion systems during the first half of the pandemic. The lockdowns and restrictions imposed by governments globally resulted in reduced patient visits to hospitals, a reduced number of surgeries, and a slowdown in R&D activities. However, with the increasing efforts of the government and healthcare professionals to curb the spread of the virus and prepare for similar events in the future, the market began to recover in 2021 and is expected to flourish during the forecast period.

Perfusion Systems Market Report Highlights

  • Based on application, the perfusion systems market is segmented into cardiopulmonary perfusion system, cell perfusion system, and ex-vivo organ perfusion system. The cardiopulmonary perfusion system dominated the market in 2022 due to the high prevalence of cardiac diseases globally
  • In terms of region, North America accounted for the highest market share in 2022. The rising incidences of chronic disorders, a well-established healthcare sector, and a rise in the number of organ donors are driving the regional market growth
  • The COVID-19 pandemic had a significant negative impact on the market for perfusion systems. Factors such as the change in healthcare priorities, social distancing, and global lockdowns resulted in a reduced number of surgeries and a fall in the number of organ donations and transplants
  • The coronavirus outbreak led to a decline in the sales of perfusion systems; however, post the first wave of the pandemic, the market recovered and is expected to reach its pre-COVID growth level during the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Technology
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Material outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Perfusion System Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing prevalence of cardiovascular and respiratory diseases
      • 3.4.1.2. Rising number of organ transplantations
      • 3.4.1.3. Growth in Aging Population, Increasing Incidence of Multiple Organ Failures
      • 3.4.1.4. Government and NGO Initiatives to Encourage Organ Donation
      • 3.4.1.5. Increasing Investments in Cell - Based Research
      • 3.4.1.6. Increase in Biologic Manufacturing
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High Cost of Organ Transplantation
      • 3.4.2.2. Ethical Concerns and High Cost of Cell - Based Research
  • 3.5. Perfusion System Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Perfusion System: Application Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Cardiopulmonary Perfusion System
    • 4.1.2. Cell Perfusion System
    • 4.1.3. Ex - Vivo Organ Perfusion System
  • 4.2. Product Market Share, 2021 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Perfusion System Market by Application Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Cardiopulmonary Perfusion System
      • 4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.2. Oxygenators
      • 4.5.1.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.3. Heart - Lung Machine
      • 4.5.1.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.4. Perfusion Pumps
      • 4.5.1.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.5. Cannula
      • 4.5.1.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.6. Monitoring System
      • 4.5.1.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.7. Others
      • 4.5.1.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Cell Perfusion System
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.2. Bioreactor Perfusion System
      • 4.5.2.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.3. Microfluidic Perfusion System
      • 4.5.2.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.4. Gravity/Pressure - driven Perfusion System
      • 4.5.2.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.5. Small Mammal Organ Perfusion System
      • 4.5.2.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Ex - vivo Perfusion System
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.3.2. Hypothermic Perfusion System
      • 4.5.3.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.3.3. Normothermic Perfusion System

Chapter 5. Perfusion System Market: Regional Estimates & Trend Analysis

  • 5.1. Regional market share analysis, 2022 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Regional Market Share and Leading Players, 2022
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East and Africa
  • 5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East and Africa
  • 5.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
  • 5.7. North America
    • 5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. U.S.
      • 5.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. Canada
      • 5.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.8. Europe
    • 5.8.1. U.K.
      • 5.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.2. Germany
      • 5.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.3. France
      • 5.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.4. Italy
      • 5.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.5. Spain
      • 5.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.6. Russia
      • 5.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.9. Asia Pacific
    • 5.9.1. China
      • 5.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.2. Japan
      • 5.9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.3. India
      • 5.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.4. Australia
      • 5.9.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.5. South Korea
      • 5.9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.6. Singapore
      • 5.9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.10. Latin America
    • 5.10.1. Brazil
      • 5.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.10.2. Mexico
      • 5.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.10.3. Argentina
      • 5.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.11. MEA
    • 5.11.1. Saudi Arabia
      • 5.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.11.2. South Africa
      • 5.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.11.3. UAE
      • 5.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Innovators
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2022
    • 6.3.4. Getinge AB
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Medtronic, plc.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. LivaNova,.
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Terumo Corporation
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Nipro Corporation
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. XENIOS AG
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Repligen Corporation
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Spectrum Laboratories, Inc.
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Merck KGaA.
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Harvard Bioscience, Inc.
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. ALA Scientific Instruments, Inc.
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives
    • 6.3.15. Lifeline Scientific, Inc.
      • 6.3.15.1. Company overview
      • 6.3.15.2. Financial performance
      • 6.3.15.3. Product benchmarking
      • 6.3.15.4. Strategic initiatives
    • 6.3.16. XVIVO Perfusion AB
      • 6.3.16.1. Company overview
      • 6.3.16.2. Financial performance
      • 6.3.16.3. Product benchmarking
      • 6.3.16.4. Strategic initiatives